<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04376281</url>
  </required_header>
  <id_info>
    <org_study_id>MD.241-2019</org_study_id>
    <nct_id>NCT04376281</nct_id>
  </id_info>
  <brief_title>The Effect of Norepinephrine on Cardiac Output in Patients Undergoing Liver Transplant .</brief_title>
  <official_title>The Effect of Norepinephrine on Blood Volume Cardiac , Output and Systemic Filling Pressure in Patients Undergoing Liver Transplant .</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Early administration of NE in liver transplant recipient might enhance cardiac output through&#xD;
      an increase in cardiac preload .&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The derangement of circulatory blood volume in patients with liver cirrhosis makes&#xD;
      intraoperative fluid management during liver transplant is challenging . Cirrhotic patients&#xD;
      not only have large blood volume but abnormal blood volume distribution, with a substantial&#xD;
      fraction of this volume in the splanchnic circulation (. These hemodynamic changes render&#xD;
      volume loading in these patients has little impact on CO because a large proportion of&#xD;
      infused fluid is shifted to the splanchnic system . In addition, patients with liver&#xD;
      cirrhosis is similar to septic patients who have increased total vascular compliance which&#xD;
      may cause pooling of blood in venous pool. Several studies in patients with sepsis found that&#xD;
      use of low dose vasopressor may convert unstressed blood volume (i.e the amount of blood not&#xD;
      causing pressure on the vessels) to stressed volume (i.e additional blood causing a&#xD;
      distending pressure on the vascular walls and reflects the effective circulating volume) .&#xD;
      However, no previous studies tested the effect of using norepinephrine (NE) on venous return&#xD;
      and cardiac preload in patients undergoing liver transplant. An obvious advantage of this&#xD;
      possibility is that NE will be used instead of true ﬂuid replacement which may minimize fluid&#xD;
      replacement during operation.&#xD;
&#xD;
      Recently, a method was described to estimate the changes in intravascular volume and vascular&#xD;
      capacitance by calculating mean systemic ﬁlling pressure (MSFP) . MSFP is the driving&#xD;
      pressure in venous return, and it allows calculation of the arterial and venous components of&#xD;
      systemic vascular resistance .&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 15, 2019</start_date>
  <completion_date type="Actual">October 1, 2021</completion_date>
  <primary_completion_date type="Actual">August 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The effect of Noradrenaline on change of cardiac output .</measure>
    <time_frame>along the procedure ; from skin incision to the end of surgery</time_frame>
    <description>The effect of Noradrenaline on change of cardiac output .</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The effect of NE on mean systemic filling pressure .</measure>
    <time_frame>along the procedure ; from skin incision to the end of surgery</time_frame>
    <description>The effect of NE on mean systemic filling pressure .</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The effect of NE on venous return .</measure>
    <time_frame>along the procedure ; from skin incision to the end of surgery</time_frame>
    <description>The effect of NE on venous return .</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The effect of NE on central venous pressure .</measure>
    <time_frame>along the procedure ; from skin incision to the end of surgery</time_frame>
    <description>The effect of NE on central venous pressure .</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">31</enrollment>
  <condition>Liver Transplantation</condition>
  <arm_group>
    <arm_group_label>Noradrenaline group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Noradrenaline</intervention_name>
    <description>Noradrenaline infusion for patients undergoing liver transplantaion from living donor .</description>
    <arm_group_label>Noradrenaline group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All Adults (age &gt; 18 years) patients undergoing living donor liver transplant (LDLT)&#xD;
             will be considered for inclusion in the study..&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients less than 18 years.&#xD;
&#xD;
          -  Patients undergoing liver transplantation for acute liver failure .&#xD;
&#xD;
          -  All Chronic Hypertensive patients on medication , whether controlled on not controlled&#xD;
&#xD;
          -  Those with high risk of post transplant renal dysfunction (serum creatinine &gt;1.5 mg/dL&#xD;
             at time of transplant)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed M Mukhtar, MD</last_name>
    <role>Study Director</role>
    <affiliation>professor</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>kasr El Ainy school of medicine</name>
      <address>
        <city>Cairo</city>
        <zip>11211</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Rudnick MR, Marchi LD, Plotkin JS. Hemodynamic monitoring during liver transplantation: A state of the art review. World J Hepatol. 2015 Jun 8;7(10):1302-11. doi: 10.4254/wjh.v7.i10.1302. Review.</citation>
    <PMID>26052376</PMID>
  </reference>
  <reference>
    <citation>Møller S, Bendtsen F, Henriksen JH. Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis. Gastroenterology. 1995 Dec;109(6):1917-25.</citation>
    <PMID>7498657</PMID>
  </reference>
  <reference>
    <citation>Mukhtar A, Dabbous H. Modulation of splanchnic circulation: Role in perioperative management of liver transplant patients. World J Gastroenterol. 2016 Jan 28;22(4):1582-92. doi: 10.3748/wjg.v22.i4.1582. Review.</citation>
    <PMID>26819524</PMID>
  </reference>
  <reference>
    <citation>Maas JJ, Geerts BF, van den Berg PC, Pinsky MR, Jansen JR. Assessment of venous return curve and mean systemic filling pressure in postoperative cardiac surgery patients. Crit Care Med. 2009 Mar;37(3):912-8. doi: 10.1097/CCM.0b013e3181961481.</citation>
    <PMID>19237896</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>April 15, 2020</study_first_submitted>
  <study_first_submitted_qc>May 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 6, 2020</study_first_posted>
  <last_update_submitted>November 8, 2021</last_update_submitted>
  <last_update_submitted_qc>November 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Amr Hussein Sayed</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Liver transplantaion , fluid management , noradrenaline</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Norepinephrine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

